Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
about
Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysisBench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patientsPrevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial.Measures used to treat contrast-induced nephropathy: overview of reviewsA meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.Contrast nephropathyThe Efficacy of Hydration with Normal Saline Versus Hydration with Sodium Bicarbonate in the Prevention of Contrast-induced NephropathyN-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures.Contrast-induced acute kidney injury: short- and long-term implications.N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial.Emerging drugs for renal failure.Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.Preventing contrast nephropathy: what is the best strategy? A review of the literature.N-acetylcysteine in the prevention of radiocontrast-induced nephropathy: clinical trials and end points.Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.Trimetazidine in the prevention of contrast-induced nephropathy after coronary proceduresPreventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Radiocontrast-induced acute renal failure.Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy.Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategiesEffectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsN-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?Contrast material-induced renal failure: an overview.Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CTSodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinicIncidence and outcomes of contrast-induced AKI following computed tomography.Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine levelFactors associated with the use of preventive care for contrast-induced acute kidney injuryN-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.Pharmacological strategies to prevent contrast-induced acute kidney injury.Nephrotoxicity of contrast media and protective effects of acetylcysteine.Effect of preoperative N-acetylcysteine on postoperative blood loss parameters in cardiac surgery patientsThe role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis.Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials.Prevention of contrast-induced nephropathy: a single center randomized study.A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media.Gender as a risk factor for contrast nephropathy: effects of hydration and N-acetylcysteine.
P2860
Q24791960-1A71B8C4-0C68-4FCD-8F7D-B34583562C95Q24816992-B1044A99-C8D1-41A3-8434-E94CEB930F9CQ26823226-35320639-7597-4569-9737-8CAFC911AA16Q26849704-06B34CDB-BD1F-4398-AA96-9BBA6355B75AQ33305487-59631E13-1ED5-4D7B-A4C3-5F94C9EEBF95Q33723450-6105C50C-8371-4AE9-A578-14C752029382Q34013959-5EEF2A69-E474-4F03-BE2C-C0D7E60BF070Q34722709-CDE0F239-D708-4882-B203-6B2479B422D7Q35124685-3A565F05-EFFF-47A2-91F4-FE05837E1C7BQ35127308-04893E87-A4D3-43BA-B4C7-E8309B0FC74BQ35584286-8CDAC1CF-01F7-445F-96C1-690B4BE1B908Q35602657-C6ED0F9E-A786-4367-AF48-D0C0F3CB195DQ35616173-67E89FE2-EDA2-402C-8B0B-9F3789AB251EQ35722883-7B88897E-3646-4678-99C0-EF2FBE0DFE17Q35838007-23A93A73-883A-45A0-8907-38418DDD3BF7Q35951153-2373EC3E-C2B7-49AD-BEB5-9846BFBDF08FQ35954734-FE8BEE2B-2080-48E6-A7A1-AF677C97468DQ35999430-1E32A0D0-FA26-4B14-8757-9AF3BBA90456Q36108253-3332EDD0-D981-4821-949F-069ED17DA777Q36122228-C163E264-0082-4959-937A-160A2AEC319FQ36136330-8F51538A-7DAD-43D0-B0A4-4C91C48DA55DQ36143434-59C32B58-7248-4444-A7E0-1A44C45B540BQ36277926-C02C2F41-8D83-4A1F-813A-884000D7D8DFQ36335159-B71A8E38-9015-432F-81E6-E172C57A3867Q36425063-1C2E9009-8E6F-4EF2-AA92-8F9BCD49320FQ36666993-25B5783A-BB11-4FF0-8737-93E3A2819A93Q36843369-61BD6856-91DB-4804-83CB-2A0D048C7125Q36969377-41BBEE22-224B-48C4-9D68-DF7218A03A9CQ37096902-979D6FFC-4C22-4A48-B9AF-CD38A58B2559Q37271293-EA707656-719E-4D16-8747-8FA0BF86E2D5Q37639849-CBFFE46C-563D-4F31-87A5-181E01C2742CQ37817813-3DE4003C-8EB6-410B-8A71-242CF0A0CA81Q37901398-A5673BE3-F950-41E5-B8C4-AC9167F8F70CQ38063188-BCDA4D78-0E4F-4180-9E84-2DBEEF8DC0BAQ38623589-8B53ED0A-26BE-487B-800B-5337B1FF47FAQ38916695-D828784B-5BD3-439A-8F48-A2C928B0240FQ43175944-86AAFFB0-FA16-408B-A3F0-5CDD991098D8Q44221325-D6A92183-A9F2-4641-BBFE-9F08EFE97339Q44805617-F9ED1857-D93D-4465-8B2F-69A4A04451A6Q45155913-C3E2946A-6DF0-4859-AA45-43B819D34885
P2860
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@en
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@nl
type
label
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@en
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@nl
prefLabel
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@en
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@nl
P2093
P1476
Acetylcysteine protects agains ...... dergoing a coronary procedure.
@en
P2093
Jun Jack Cheng
Kou Gi Shyu
Peiliang Kuan
P304
P356
10.1016/S0735-1097(02)02308-2
P407
P577
2002-10-01T00:00:00Z